BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 3111844)

  • 41. Transforming growth factor-beta induces plasminogen activator inhibitor type-1 in cultured human orbital fibroblasts.
    Cao HJ; Hogg MG; Martino LJ; Smith TJ
    Invest Ophthalmol Vis Sci; 1995 Jun; 36(7):1411-9. PubMed ID: 7775119
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells.
    Arnoletti JP; Albo D; Granick MS; Solomon MP; Castiglioni A; Rothman VL; Tuszynski GP
    Cancer; 1995 Sep; 76(6):998-1005. PubMed ID: 8625226
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Measurements of the concentration of free plasminogen activator inhibitor (PAI-1) and its complex with tissue plasminogen activator in human plasma.
    Takada Y; Takada A
    Thromb Res Suppl; 1988; 8():15-22. PubMed ID: 3144765
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential regulation of mesothelial cell fibrinolysis by transforming growth factor beta 1.
    Falk P; Ma C; Chegini N; Holmdahl L
    Scand J Clin Lab Invest; 2000 Oct; 60(6):439-47. PubMed ID: 11129059
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulation of plasminogen activator inhibitor-1 mRNA accumulation by basic fibroblast growth factor and transforming growth factor-beta1 in cultured rat astrocytes.
    Treichel JA; Reddington M; Kreutzberg GW
    J Neurochem; 1998 Nov; 71(5):1944-52. PubMed ID: 9798919
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glucocorticoid induction of plasminogen activator and plasminogen activator-inhibitor messenger RNA in rat hepatoma cells.
    Heaton JH; Gelehrter TD
    Mol Endocrinol; 1989 Feb; 3(2):349-55. PubMed ID: 2469009
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of a plasminogen activator and its inhibitor in human mesangial cells.
    Lacave R; Rondeau E; Ochi S; Delarue F; Schleuning WD; Sraer JD
    Kidney Int; 1989 Mar; 35(3):806-11. PubMed ID: 2496257
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytokine modulation of plasminogen activator inhibitor-1 (PAI-1) production by human articular cartilage and chondrocytes. Down-regulation by tumor necrosis factor alpha and up-regulation by transforming growth factor-B basic fibroblast growth factor.
    Campbell IK; Wojta J; Novak U; Hamilton JA
    Biochim Biophys Acta; 1994 Jul; 1226(3):277-85. PubMed ID: 8054359
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells.
    Saksela O; Moscatelli D; Rifkin DB
    J Cell Biol; 1987 Aug; 105(2):957-63. PubMed ID: 3114269
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasminogen activator regulation in osteoblasts: parathyroid hormone inhibition of type-1 plasminogen activator inhibitor and its mRNA.
    Fukumoto S; Allan EH; Yee JA; Gelehrter TD; Martin TJ
    J Cell Physiol; 1992 Aug; 152(2):346-55. PubMed ID: 1322417
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Platelet-derived growth factor and transforming growth factor-beta regulate plasminogen activator inhibitor-1 synthesis in vascular smooth muscle cells.
    Reilly CF; McFall RC
    J Biol Chem; 1991 May; 266(15):9419-27. PubMed ID: 2033043
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of cellular transformation on expression of plasminogen activator inhibitors 1 and 2. Evidence for independent regulation.
    Cohen RL; Niclas J; Lee WM; Wun TC; Crowley CW; Levinson AD; Sadler JE; Shuman MA
    J Biol Chem; 1989 May; 264(14):8375-83. PubMed ID: 2498314
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells.
    Pöllänen J; Saksela O; Salonen EM; Andreasen P; Nielsen L; Danø K; Vaheri A
    J Cell Biol; 1987 Apr; 104(4):1085-96. PubMed ID: 3104349
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transforming growth factor beta alters plasminogen activator activity in human skin fibroblasts.
    Laiho M; Saksela O; Keski-Oja J
    Exp Cell Res; 1986 Jun; 164(2):399-407. PubMed ID: 3519251
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasminogen activator inhibitor type-1 protein, mRNA and gene transcription are increased by phorbol esters in human rhabdomyosarcoma cells.
    Mayer M; Lund LR; Riccio A; Skouv J; Nielsen LS; Stacey SN; Danø K; Andreasen PA
    J Biol Chem; 1988 Oct; 263(30):15688-93. PubMed ID: 3262618
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transforming growth factor beta stimulates urokinase-type plasminogen activator and DNA synthesis, but not prostaglandin E2 production, in human synovial fibroblasts.
    Hamilton JA; Piccoli DS; Leizer T; Butler DM; Croatto M; Royston AK
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7180-4. PubMed ID: 1908092
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transforming growth factor beta stimulates the expression of fibronectin and of both subunits of the human fibronectin receptor by cultured human lung fibroblasts.
    Roberts CJ; Birkenmeier TM; McQuillan JJ; Akiyama SK; Yamada SS; Chen WT; Yamada KM; McDonald JA
    J Biol Chem; 1988 Apr; 263(10):4586-92. PubMed ID: 2965146
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transforming growth factor-beta1 produced by ovarian cancer cell line HRA stimulates attachment and invasion through an up-regulation of plasminogen activator inhibitor type-1 in human peritoneal mesothelial cells.
    Hirashima Y; Kobayashi H; Suzuki M; Tanaka Y; Kanayama N; Terao T
    J Biol Chem; 2003 Jul; 278(29):26793-802. PubMed ID: 12743121
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cyclic nucleotide regulation of plasminogen activator and plasminogen activator-inhibitor messenger RNAs in rat hepatoma cells.
    Heaton JH; Gelehrter TD
    Mol Endocrinol; 1990 Jan; 4(1):171-8. PubMed ID: 2157975
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Smad6s regulates plasminogen activator inhibitor-1 through a protein kinase C-beta-dependent up-regulation of transforming growth factor-beta.
    Berg DT; Myers LJ; Richardson MA; Sandusky G; Grinnell BW
    J Biol Chem; 2005 Apr; 280(15):14943-7. PubMed ID: 15716278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.